1. Outcome of transition phase patients with juvenile idiopathic arthritis
- Author
-
Silja Kosola, Riitta Luosujärvi, Heikki Relas, Reumatologian yksikkö, Department of Medicine, Clinicum, Children's Hospital, Lastentautien yksikkö, HUS Children and Adolescents, and HUS Inflammation Center
- Subjects
Male ,Pediatrics ,medicine.medical_specialty ,Adolescent ,Treatment adherence ,Arthritis ,CATEGORIES ,Adult care ,Adolescents ,smoking ,THERAPIES ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,transition of care ,Rheumatology ,Quality of life ,QUALITY-OF-LIFE ,3123 Gynaecology and paediatrics ,YOUNG-ADULTS ,disease-modifying antirheumatic drugs ,medicine ,Humans ,DISEASE-ACTIVITY SCORE ,Juvenile ,COHORT ,030212 general & internal medicine ,Young adult ,030203 arthritis & rheumatology ,business.industry ,FINLAND ,medicine.disease ,HLA-B27 PREDICTS ,Arthritis, Juvenile ,RHEUMATOID-ARTHRITIS ,3. Good health ,CLINICAL REMISSION ,Antirheumatic Agents ,3121 General medicine, internal medicine and other clinical medicine ,Rheumatoid arthritis ,Cohort ,Female ,juvenile idiophatic arthritis ,business - Abstract
Objectives: Across diagnosis groups, successful transition of adolescent and young adults from children's hospitals to adult care is often associated with decreased treatment adherence and treatment results. The aim of this study was to characterize disease activity and anti-rheumatic medications following transfer of care of juvenile idiopathic arthritis (JIA) patients to the adult clinic.Method: All consecutive JIA patients aged 16-20 years who visited the specific transition clinic in the rheumatology outpatient clinic of Helsinki University Hospital between November 2012 and May 2013 and between April 2015 and April 2016 were evaluated.Results: A total of 214 patients were identified, and 23 appeared in both cohorts. Females had higher disease activity scores (DAS) than males (DAS28-CRP 1.90.7 versus 1.6 +/- 0.3, p=.019; and DAS44-CRP 1.0 +/- 0.7 versus 0.7 +/- 0.5, p=.005; respectively) in the latter cohort. Disease-modifying antirheumatic drugs (DMARDs) were prescribed to 86% of patients, and 48% were on biological DMARDs (bDMARDs), whereas 14% had no specific treatments.Conclusion: Disease activity and clinic attendance remained stable during the transition period. The proportion of transition phase JIA patients on bDMARDs was high and disease activity was low. Reasons for lower disease activity in males in the latter cohort require further investigation.
- Published
- 2018